Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satraplatin and BRCAness in mCRPC
NCT01289067Phase 2Completed
- Start
- Dec 2010
- Primary completion
- May 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of satraplatin in metastatic castration-resistant prostate cancer (mCRPC). Started Dec 2010; status: completed.
02
Drugs
satraplatin
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT01289067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289067.